Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESRRG | P62508 | 16/20 | 0.68 |
| ▸ | ESRRB | O95718 | 6/20 | 0.68 |
| ▸ | ESR1 | P03372 | 7/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24688914 | 0.91 | ESRRG (0.66) | ESRRGESRRBESR1KCNH2HRH3 | |
| SCHEMBL24688546 | 0.82 | ESRRG (0.67) | ESRRGESRRBESR1KCNH2 | |
| SCHEMBL20842018 | 0.81 | ESRRG (1.00) | ESRRGESRRBESR1KCNH2 | |
| SCHEMBL24688550 | 0.78 | ESRRG (0.52) | ESRRGESRRBESR1KCNH2 | |
| SCHEMBL24688554 | 0.77 | ESRRG (0.61) | ESRRGESRRBESR1KCNH2 | |
| SCHEMBL21066254 | 0.77 | ESRRG (0.81) | ESRRGESRRBESR1KCNH2 | |
| SCHEMBL24688559 | 0.77 | ESRRG (0.64) | ESRRGESRRBESR1KCNH2 | |
| SCHEMBL24354524 | 0.76 | ESRRG (0.98) | ESRRGESRRBESR1KCNH2 | |
| SCHEMBL20842220 | 0.76 | ESRRG (0.98) | ESRRGESRRBESR1KCNH2 | |
| SCHEMBL2389123 | 0.75 | DRD2 (0.60) | ESRRGESRRBKCNH2HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022245124-A1 | NOVEL ETHENE COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | 재단법인 대구경북첨단의료산업진흥재단 | 2022-11-24 | — | — | WO | disclosed |
| WO-2022245124-A1 | NOVEL ETHENE COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER | 재단법인 대구경북첨단의료산업진흥재단 | 2022-11-24 | — | — | WO | disclosed |